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Chronic obstructive pulmonary disease
(COPD) has a high prevalence in Australia. At
least 600 000 Australians are aware of being
affected by it,1 but as many may not be recog-
nised (based on a South Australian
community sample of mild COPD not previ-
ously diagnosed2). There is good evidence
that smoking cessation will halt the acceler-
ated decline in lung function in smokers with
COPD,3 therefore early identification of
smokers with COPD is important to enable
smoking interventions.
The hallmark physiological change in COPD
is expiratory airflow limitation that is not fully
reversible. This is best measured by spirome-
try, the key to the diagnosis of COPD.4
Australian guidelines for the diagnosis of
COPD (COPDX Plan) were issued by the
Thoracic Society of Australia and New Zealand
and the Australian Lung Foundation in March
2003.5 They advise the diagnosis should be
considered in all smokers and ex-smokers
over 35 years of age. Inappropriate breathless-
ness, chronic daily cough, frequent sputum
production or relapsing acute bronchitis should
be investigated with spirometry. We sought to
investigate the current use of, and attitudes
to, spirometry for COPD in general practice. 
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BACKGROUND
Guidelines advise chronic obstructive pulmonary disease (COPD) should be
diagnosed and managed by using spirometry to demonstrate irreversible airflow
limitation and monitor change in smokers and ex-smokers aged over 35 years.
METHODS
A cross-sectional study of patients and their general practitioners investigating use
of spirometry in COPD in two practices by lung function assessment, review of
practice records, interviews and focus groups.
RESULTS
Sixteen GPs, and 38 patients with a diagnosis of COPD participated. At diagnosis,
although 72% had spirometry, this occurred in only 41% of 17 patients diagnosed
by a GP; but in all 19 cases when a specialist was involved. Diagnosis often
occurred late, despite all patients having previously recorded symptoms typical of
COPD. General practitioners expressed a preference to diagnose COPD on clinical
grounds. Although 58% of patients had recent spirometry for current management,
only 32% were performed by their GP. There were organisational and technical
barriers to spirometry and poor recognition of the essential role of spirometry in
the diagnosis of COPD. 
DISCUSSION
There are a number of potentially reversible factors that hinder practice
recommendations regarding the use of spirometry in general practice to diagnose 
and manage COPD .
RESEARCH
Methods
We undertook a pilot study of a cross sec-
tional survey of patients with COPD and
their general practitioners. Patients were
either identif ied by GPs directly, or by
searching their electronic records for bron-
chodilator or theophylline use. We excluded
patients with a primary diagnosis of asthma,
another serious medical condition or signifi-
cant cognitive impairment. We extracted
data on symptoms, respiratory diagnoses,
investigations and management from the
clinical records. A sample of patients partici-
pated in semistructured interviews about
their respiratory illness with a trained inter-
viewer. Focus groups and semistructured
interviews about COPD were also con-
ducted with GPs. 
Results
In 2002, we recruited 38 patients (20
women) with a mean age of 68 years
(SD:10.6) with a recorded diagnosis of
COPD from two general practices in Hobart
(Tasmania) with a practice population across
a wide range of socioeconomic levels.
Patients completed health status question-
naires. The dates of diagnosis were
available for 36 patients, of whom 23 (13
women) were interviewed and their 16 GPs
(eight women) participated in focus groups
or interviews. The mean age of patients at
diagnosis was 60 (SD:10.6) years with a
mean history of smoking for 39 (SD:12)
years before diagnosis. 
In every case, typical  symptoms of
COPD had been recorded before diagnosis;
most frequently cough (89%) and breath-
lessness (86%), and in 78% of patients, at
least two key symptoms (cough, breathless-
ness, sputum or wheeze).
Spirometry had been performed in 72% of
patients at the time of diagnosis. Seventeen
(47%) were under the care of their GP only at
the time of diagnosis, of whom only seven
had spirometry recorded. All 19 managed by
both GP and respiratory specialist had under-
gone spirometry. The GP had performed
spirometry in only four cases when a special-
ist was also involved (Table 1). In 19 patients
(53%), the diagnosis was not made until an
acute exacerbation resulted in hospital admis-
sion, even though symptoms had been
previously recorded for up to 10 years.
Spirometry was less frequently used during
ongoing management (Table 1).
From qualitative thematic analysis of
interviews and focus groups with GPs, a
number of themes emerged that were influ-
encing the use of spirometry in COPD.
These related to the performance of spirom-
etry or resources (Table 2 ) .  General
practitioners expressed a preference to
diagnose COPD ‘clinically’ rather than on the
basis of spirometry. They described a con-
sistent pattern of situations when they
would consider the diagnosis, namely:
increasing respiratory symptoms in
smokers, increasing frequency of respiratory
infections, or the need for inhaled 
bronchodilators to be used regularly rather
than intermittently.
Other themes of GPs’ attitudes to man-
aging COPD emerged (Table 3). Interviews
with patients indicated a general lack of
knowledge about COPD; they were not
aware that regular testing of lung function
was recommended. Negative opinions
about the spirometry testing procedure
were not common.
Discussion
We found low use of spirometry by GPs for
diagnosis and continued management of
COPD. This is supported by Medicare claims
for spirometry testing from general practice:
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Table 1. Use of spirometry in COPD in general practice
At diagnosis n
By GP Spirometry by GP 7
No spirometry 10
By GP and specialist Spirometry by GP 4
Spirometry by specialist 19




Table 2. GP perceived barriers
to spirometry
• Lack of access to a well maintained
spirometer
• Lack of expertise in performance of
spirometry 
• Patient reluctance to attend a
referral centre for spirometry
• Increased cost to patients for 
longer consultations
• Time waiting for repeat spirometry
after bronchodilator 
• Low confidence in ability to
interpret spirometry results
Table 3. Attitudes of GPs to COPD
• Reluctance to make a formal
diagnosis 
• Think the term ‘emphysema’ is
disliked by patients
• Believe the acronym COPD is not
understood by patients
• Not concerned by differentiation
from asthma with spirometry
• Worry that normal spirometry is a
disincentive to quit smoking
• See COPD as one of multiple
chronic illnesses in a typical patient,
often not the most important
• Manage medication by trial of
clinical response
• Do not see regular follow up with
spirometry as useful for patients
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during 15 months from July 2002 there were
1472 claims for spirometry performed before
and after a bronchodilator made by 289 GPs
in the Tasmanian Southern Division of
General Practice; equivalent to less than five
spirometry claims per GP per year in total.6
The study was designed as a pilot to
investigate the views of local primary care
doctors caring for COPD patients and how
they influence management. It is not neces-
sarily representative of the views of all GPs,
but may give some insight into why there is
low use of spirometry in primary care. This
work highlights some potential barriers to
the use of spirometry in the diagnosis and
management of COPD that need to be
tackled to increase spirometry rates to prac-
tice guideline levels. The New South Wales
clinical services framework with standards,
recommendations, milestones and targets
for COPD was published in 2003,7 and
similar targets are likely to be adopted in
other states. According to these, by
December 2003, 100% of COPD patients
should have access to spirometry (although
the model of testing is not specified), and by
June 2004, 100% of hospital inpatients with
a smoking history of 15 pack years should
be assessed by spirometry.
The scepticism expressed by GPs about
the relevance of spirometry to the diagnosis
of COPD and a reluctance to make the diag-
nosis before acute exacerbations occur are
barriers that will need to be overcome even
if al l  GPs have access to spirometry.
Although pharmacological interventions are
not known to alter the prognosis in COPD,
earlier diagnosis combined with effective
assistance to stop smoking would prevent
disease progression. Although abnormal
lung function on spirometry might increase
the motivation of smokers to attempt to
quit, this does not translate into a significant
difference in sustained quit rates.8
General practitioners may require advice
on the best choice of spirometer for use in
general practice that would facilitate high
quality spirometry and access to effective
practical training for the appropriate person-
nel. A Medicare rebate for single occasion
spirometry, without the need for administra-
tion of bronchodilator, is likely to improve
use. The low use of spirometry testing in
general practice remains a barrier to a strat-
egy for earlier diagnosis of COPD. Factors
identified in this study wil l need to be
addressed if these targets are to be met in
the near future.
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Research: Barriers to the use of spirometry in general practice
• Guidelines advise that COPD should be
considered in patients aged over 35
years with a history of smoking.
• Guidelines advise that the diagnosis of
COPD should be based on spirometry.
• Spirometry may be important in
slowing the progression of COPD by
encouraging more smokers to give up. 
• COPD was often diagnosed in our
study without measurement of lung
function.
• There are barriers to use of spirometry
in primary care.
• A Medicare rebate for single occasion
testing and GP training in spirometry
may increase use.
Implications of this study 
for general practice
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